Two North American companies have announced collaborations with established drug delivery firms to produce and expand distribution for oral CBD strips – soluble strips that dissolve in the mouth.

Tilray, one of the largest cannabis companies, has signed a licence, development and supply agreement with IntelGenx, an oral drug delivery company. Together the two Canadian companies will fund, develop and commercialise an oral film product with medical cannabis and adult-use purposes.

Meanwhile, California-based Chemesis International will partner Rapid Dose Therapeutics, a Canadian biotechnology company, to distribute QuickStrips Oral Thin Strips in California and Puerto Rico.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us